Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37959

1.

Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis.

Sedhom D, Herrmann A, D'Souza M, Fyfe B, Zaldana F, Schlesinger N, Rustgi V.

ACG Case Rep J. 2018 Dec 19;5:e95. doi: 10.14309/crj.2018.95. eCollection 2018.

PMID:
30643839
2.

Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and clinical implications.

Abuduxikuer K, Chen R, Wang ZL, Wang JS.

BMC Pediatr. 2019 Jan 14;19(1):18. doi: 10.1186/s12887-018-1383-5.

PMID:
30642297
3.

Neuromuscular manifestations of primary biliary cholangitis: two case reports and literature review.

Brites L, Ribeiro J, Luis M, Santiago M, Negrão L, Duarte C.

Acta Reumatol Port. 2018 Oct-Dec;43(4):304-308.

PMID:
30641539
4.

Lysophosphatidic acid activates satellite glia cells and Schwann cells.

Robering JW, Gebhardt L, Wolf K, Kühn H, Kremer AE, Fischer MJM.

Glia. 2019 Jan 13. doi: 10.1002/glia.23585. [Epub ahead of print]

PMID:
30637823
5.

Risk factors for perforation during endoscopic retrograde cholangiopancreatography in post-reconstruction intestinal tract.

Takano S, Fukasawa M, Shindo H, Takahashi E, Hirose S, Fukasawa Y, Kawakami S, Hayakawa H, Yokomichi H, Kadokura M, Sato T, Enomoto N.

World J Clin Cases. 2019 Jan 6;7(1):10-18. doi: 10.12998/wjcc.v7.i1.10.

PMID:
30637248
6.

Therapeutic Roles of Bile Acid Signaling in Chronic Liver Diseases.

Li Y, Lu LG.

J Clin Transl Hepatol. 2018 Dec 28;6(4):425-430. doi: 10.14218/JCTH.2018.00025. Epub 2018 Oct 25. Review.

PMID:
30637221
7.

[Progressive familial intrahepatic cholestasis type 3].

Lipiński P, Jankowska I.

Dev Period Med. 2018;22(4):385-389. Polish.

PMID:
30636238
8.

Cholemic nephropathy causes acute kidney injury and is accompanied by loss of aquaporin 2 in collecting ducts.

Bräsen JH, Mederacke YS, Schmitz J, Diahovets K, Khalifa A, Hartleben B, Person F, Wiech T, Steenbergen E, Großhennig A, Manns MP, Schmitt R, Mederacke I.

Hepatology. 2019 Jan 11. doi: 10.1002/hep.30499. [Epub ahead of print]

PMID:
30633816
9.

Gastric Outlet Obstruction due to Intramural Duodenal Hematoma after Endoscopic Biopsy: Possible Therapeutic Role of Endoscopic Dilation.

Samra M, Al-Mouradi T, Berkelhammer C.

Case Rep Gastroenterol. 2018 Nov 28;12(3):692-698. doi: 10.1159/000494967. eCollection 2018 Sep-Dec.

10.

Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids as a Marker of Cholestatic Drug Potential.

Burban A, Sharanek A, Humbert L, Eguether T, Guguen-Guillouzo C, Rainteau D, Guillouzo A.

Toxicol Sci. 2019 Jan 10. doi: 10.1093/toxsci/kfz009. [Epub ahead of print]

PMID:
30629237
11.

Hepatic Lesions Associated with McCune Albright Syndrome.

Johansen L, Haller W, Thyagarajan M, Kelly D, McKiernan P.

J Pediatr Gastroenterol Nutr. 2019 Jan 4. doi: 10.1097/MPG.0000000000002266. [Epub ahead of print]

PMID:
30628989
12.

Congenital Portosystemic Shunts: Current Diagnosis and Management.

McLin VA, Franchi-Abella S, Debray D, Guérin F, Beghetti M, Savale L, Wildhaber BE, Gonzales E; Members of the International Registry of Congenital Porto-Systemic Shunts.

J Pediatr Gastroenterol Nutr. 2019 Jan 4. doi: 10.1097/MPG.0000000000002263. [Epub ahead of print]

PMID:
30628988
13.

Dyslipidemia, subclinical inflammation, hepatic cholestasis and endothelial dysfunction in schoolchildren with excess fat: A study from the United Arab Emirates.

Aburawi EH, Al Hamad S, Yasin J, Almekhaini LA, Souid AK.

PLoS One. 2019 Jan 9;14(1):e0210316. doi: 10.1371/journal.pone.0210316. eCollection 2019.

14.

Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis.

George J, Tsuchishima M, Tsutsumi M.

Cell Death Dis. 2019 Jan 8;10(1):18. doi: 10.1038/s41419-018-1272-8.

15.

Transient elastography correlated with diffusion-weighted magnetic resonance imaging and cholestatic complications.

Lee CZ, Peng SS, Lee CS, Chen HL, Ni YH, Chang MH, Wu JF.

J Formos Med Assoc. 2019 Jan 6. pii: S0929-6646(18)30622-3. doi: 10.1016/j.jfma.2018.12.018. [Epub ahead of print]

16.

SMOFlipid Protects Preterm Neonates against Perinatal Nutrition-Associated Cholestasis.

Kasirer Y, Bin-Nun A, Raveh A, Schorrs I, Mimouni FB, Hammerman C.

Am J Perinatol. 2019 Jan 8. doi: 10.1055/s-0038-1676977. [Epub ahead of print]

PMID:
30620942
17.

Constitutive Androstane Receptor Differentially Regulates Bile Acid Homeostasis in Mouse Models of Intrahepatic Cholestasis.

Kim KH, Choi JM, Li F, Dong B, Wooton-Kee CR, Arizpe A, Anakk S, Jung SY, Hartig SM, Moore DD.

Hepatol Commun. 2018 Dec 4;3(1):147-159. doi: 10.1002/hep4.1274. eCollection 2019 Jan.

18.

Celastrol protects from cholestatic liver injury though modulation of SIRT1-FXR signaling.

Zhao Q, Liu F, Cheng Y, Xiao XR, Hu DD, Tang YM, Bao WM, Yang JH, Jiang T, Hu JP, Gonzalez F, Li F.

Mol Cell Proteomics. 2019 Jan 7. pii: mcp.RA118.000817. doi: 10.1074/mcp.RA118.000817. [Epub ahead of print]

19.

Effect of plasmapheresis on cholestatic pruritus and autotaxin activity during pregnancy.

Heerkens M, Dedden S, Scheepers H, Van Paassen P, Masclee A, de Die-Smulders C, Olde Damink SWM, Schaap FG, Jansen P, Koek G, Beuers U, Verbeek J.

Hepatology. 2019 Jan 7. doi: 10.1002/hep.30496. [Epub ahead of print]

PMID:
30614557
20.

Association between bile salt export pump polymorphisms and intrahepatic cholestasis of pregnancy susceptibility: a meta-analysis of case-control studies.

Zhou J, Yao Y, Huang X, Chen D, Zhang T, Zhang Y.

Gynecol Endocrinol. 2019 Jan 6:1-5. doi: 10.1080/09513590.2018.1512570. [Epub ahead of print]

PMID:
30614300

Supplemental Content

Loading ...
Support Center